Prime Medicine (PRME) Preferred Dividend Payments (2021 - 2022)

Prime Medicine (PRME) posted Preferred Dividend Payments of $1.3 million for Q4 2022, down 79.35% on a QoQ basis from $6.4 million in Q3 2022.

Prime Medicine (PRME) Preferred Dividend Payments (2021 - 2022) Analysis & Trends

Prime Medicine's Preferred Dividend Payments history runs 2 years deep, the most recent figure standing at $1.3 million for Q4 2022.

Quarterly Preferred Dividend Payments changed N/A year-over-year to $1.3 million in Q4 2022, while the trailing twelve-month figure through Sep 2023 was $1.3 million (down 93.04% YoY) and the FY2022 annual result came in at $20.2 million, up 1275.54% from the prior year.
Preferred Dividend Payments was $1.3 million for Q4 2022 at Prime Medicine, down from $6.4 million in the prior quarter.
Across five years, Preferred Dividend Payments topped out at $6.4 million in Q3 2021 and bottomed at $1.3 million in Q4 2022.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Pref Dividends (Qtr)
1	Oculis Holding AG	68,785.72 Bn	68,785.72 Bn	-	-
2	Nanobiotix	1,895.57 Bn	1,895.51 Bn	-	-
3	BeOne Medicines	471.35 Bn	466.56 Bn	1.35 Bn	-
4	NuCana	279.75 Bn	279.75 Bn	-	-
5	Vertex Pharmaceuticals	120.24 Bn	113.00 Bn	2.59 Bn	-
6	Regeneron Pharmaceuticals	67.80 Bn	59.04 Bn	3.31 Bn	-
7	Belite Bio	62.51 Bn	62.51 Bn	-	-
8	Argenx Se	57.38 Bn	57.38 Bn	1.41 Bn	-
9	Revolution Medicines	37.78 Bn	37.78 Bn	-	-
10	Prime Medicine	525.98 Mn	525.98 Mn	-	-

Download Data